Readmission - Roquefort Therapeutics Plc
In brief · summary, not quotable
Roquefort Therapeutics PLC's ordinary shares of 1p each have been cancelled from admission to trading on the London Stock Exchange, effective March 27, 2026, following a transfer to AIM.
Full announcement
Select text to share a quote on X · sign in to keep highlights & notes in your COIL notes
27/03/2026 - 08:00
ROQUEFORT THERAPEUTICS PLC
254900P4SISIWOR9RH34
| ORDINARY SHARES OF 1P EACH FULLY PAID | (BMDQ2T1)(GB00BMDQ2T15) | ROQT THER/PAR VTG FPD 0.01 |
If you have any queries relating to the above content, please contact us on +44 (0) 20 7797 4310.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.